Suraksha Diagnostic IPO Details: The Suraksha Diagnostic IPO is scheduled to open on November 29, 2024, and close on December 3, 2024. This is a Book Built Issue IPO, aiming to raise approximately ₹846.25 crores. The offer comprises a fresh issue of ₹[.] crores and an offer for sale (OFS) of up to 1,91,89,330 equity shares with a face value of ₹2 each.
The price band for the IPO is set between ₹420 and ₹441 per share. The allocation quota includes 35% for retail investors, 50% for Qualified Institutional Buyers (QIBs), and 15% for High Net-worth Individuals (HNIs). The IPO is expected to be listed on BSE and NSE on December 6, 2024, with the allotment date slated for December 4, 2024.
In terms of financial performance, the company reported revenue of ₹218.71 crores in 2024, an increase from ₹190.13 crores in 2023. Similarly, the net profit rose significantly to ₹23.13 crores in 2024, up from ₹6.07 crores in 2023. Given these promising financials, the IPO presents a compelling opportunity for investors, particularly those seeking long-term growth.
Suraksha Diagnostic IPO Objectives:
The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.
Suraksha Diagnostic IPO Review (Apply or Not)
- May Apply
Suraksha Diagnostic IPO Date & Price Band Details:
| IPO Open Date: | November 29, 2024 |
| IPO Close Date: | December 3, 2024 |
| Face Value: | ₹2 Per Equity Share |
| IPO Price Band: | ₹420 to ₹441 Per Share |
| Issue Size: | Approx ₹846.25 Crores |
| Offer for Sale: | Approx 1,91,89,330 Equity Shares |
| Issue Type: | Book Built Issue |
| IPO Listing: | BSE & NSE |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Suraksha Diagnostic IPO Lot Size:
The minimum market lot for the Suraksha Diagnostic IPO consists of 34 shares, requiring a minimum application amount of ₹14,994. Retail investors can apply for up to 13 lots, equivalent to 442 shares, with a maximum application amount of ₹1,94,922.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 34 | ₹14,994 |
| Retail Maximum | 13 | 442 | ₹1,94,922 |
| S-HNI Minimum | 14 | 476 | ₹2,09,916 |
| S-HNI Maximum | 66 | 2,244 | ₹9,89,604 |
| B-HNI Minimum | 67 | 2,278 | ₹1,004,598 |
Suraksha Diagnostic IPO Timeline:
The Suraksha Diagnostic IPO is set to open on November 29, 2024, and will close on December 3, 2024. The allotment of shares is scheduled to be finalized on December 4, 2024, with the IPO expected to list on the stock exchanges on December 6, 2024.
Suraksha Diagnostic IPO GMP Today:
The most recent Grey Market Premium (GMP) for the Suraksha Clinic and Diagnostic IPO is ₹0, as of November 30, 2024, at 6:31 PM. Based on the upper price band of ₹441, the estimated listing price is also ₹441 (cap price + current GMP). This suggests an expected percentage gain/loss of 0.00% per share.
Promoters of Suraksha Diagnostic IPO
The company’s promoters are Dr. Somnath Chatterjee, Ms. Ritu Mittal, and Mr. Satish Kumar Verma.
About Suraksha Diagnostic IPO
Incorporated on March 15, 2005, Suraksha Diagnostic provides a wide range of services, including medical testing, diagnostic solutions, and medical consultation. Headquartered in eastern India, the company delivers comprehensive pathology and radiology testing services through an extensive operational network. Over the years, it has earned several awards, reflecting its strong brand recognition and business focus.
Suraksha Diagnostic boasts a robust portfolio of over 2,300 tests, encompassing:
- 788 pathology tests such as basic biochemistry and haematology.
- 647 advanced tests, including biochemistry, histopathology, and molecular pathology.
The company’s financial performance has been impressive, achieving a CAGR of 20.87% in revenue between FY 2022 and FY 2024, with a net income of ₹23.13 crore in FY 2024.
A leading diagnostic network with a dominant presence in eastern India, Suraksha Diagnostic stands out for its financial stability, profitability, and operational expertise. Supported by a dedicated workforce of 1,522 permanent employees, the company continues to set benchmarks in the diagnostic sector.
Suraksha Diagnostic IPO Company Financial Report
The company reported revenue of ₹218.71 crores in 2024 against ₹190.13 crore in 2023. The company reported Profit of ₹23.13 crores in 2024 against Profit of ₹6.07 crores in 2023.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2022 | ₹223.19 | ₹197.76 | ₹20.82 | ₹275.96 |
| 2023 | ₹190.13 | ₹186.94 | ₹6.07 | ₹281.20 |
| 2024 | ₹218.71 | ₹190.03 | ₹23.13 | ₹300.21 |
Suraksha Diagnostic IPO Valuation – FY2024
Check Suraksha Diagnostic IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 14.09% |
| ROCE: | 21.46% |
| EBITDA Margin: | 33.66% |
| PAT Margin: | 10.57% |
| Debt to equity ratio: | 0.20 |
| Earning Per Share (EPS): | ₹4.43 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 14.09% |
| Net Asset Value (NAV): | ₹33.66 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Dr Lal PathLabs | 43.05 | 68.66 | 20.35 | 221.47 | 2226.60 Cr. |
| Metropolis Healthcare | 24.95 | 82.57 | 12.26 | 213.98 | 1207.71 Cr. |
| Thyrocare | 13.42 | 47.60 | 13.34 | 99.48 | 571.88 Cr. |
| Vijaya Diagnostic | 11.62 | 67.65 | 19.77 | 64.21 | 547.81 Cr. |
Suraksha Diagnostic IPO Registrar
KFin Technologies Limited
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Phone: +91 40 6716 2222
E-mail: sdl.ipo@kfintech.com
Website: www.kfintech.com
IPO Lead Managers aka Merchant Bankers
- Nuvama Wealth and Investment Limited
Company Address
Suraksha Diagnostic Limited
Plot No. DG-12/1, Action Area 1D, Premises No. 02-0327,
New Town, Rajarhat, Kolkata 700 156, West Bengal, India
Phone: +91 33 66059750
Email: investors@surakshanet.com
Website: www.surakshanet.com
Suraksha Diagnostic IPO FAQs
1. What is the Suraksha Diagnostic IPO?
The Suraksha Diagnostic IPO is a main-board IPO through which the company aims to raise ₹846.25 crores. The price range for the issue is set at ₹420 to ₹441 per equity share, and the IPO will be listed on both the BSE and NSE.
2. When will the Suraksha Diagnostic IPO open for subscription?
The IPO will open for subscription on November 29, 2024, and will close on December 3, 2024. It is open to Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Investors.
3. What is the allocation portion for investors in the Suraksha Diagnostic IPO?
The allocation breakdown is as follows:
- 50% for QIBs
- 15% for NIIs
- 35% for Retail Investors
4. How can I apply for the Suraksha Diagnostic IPO?
You can apply through:
- ASBA online via your bank account
- UPI through your stockbroker
- Offline application via your stockbroker by filling out the IPO form.
5. What is the issue size of the Suraksha Diagnostic IPO?
The IPO issue size is ₹846.25 crores.
6. What is the price band for the Suraksha Diagnostic IPO?
The IPO price band is set at ₹420 to ₹441 per equity share.
7. What is the lot size for the Suraksha Diagnostic IPO?
The minimum lot size is 34 shares, requiring an application amount of ₹14,994.
8. What is the allotment date for the Suraksha Diagnostic IPO?
The allotment of shares will be finalized on December 4, 2024.
9. When is the listing date for the Suraksha Diagnostic IPO?
The IPO is scheduled to list on the BSE and NSE on December 6, 2024.
